Glypican-3:A molecular marker for the detection and treatment of hepatocellular carcinoma
10.1016/j.livres.2020.11.003
- Author:
Shih TSUNG-CHIEH
1
;
Wang LIJUN
;
Wang HSIAO-CHI
;
Wan Yvonne YU-JUI
Author Information
1. Department of Biochemistry and Molecular Medicine
- Keywords:
Glypican-3(GPC3);
Wnt signaling;
Hepatocellular carcinoma(HCC)
- From:
Liver Research
2020;4(4):168-172
- CountryChina
- Language:Chinese
-
Abstract:
Hepatocellular carcinoma(HCC)is a malignant tumor with a fairly poor prognosis(5-year survival of less than 50％).Using sorafenib,the only food and drug administration(FDA)-approved drug,HCC cannot be effectively treated;it can only be controlled at most for a couple of months.There is a great need to develop efficacious treatment against this debilitating disease.Glypican-3(GPC3),a member of the glypican family that attaches to the cell surface by a glycosylphosphatidylinositol anchor,is overex-pressed in HCC cases and is elevated in the serum of a large proportion of patients with HCC.GPC3 expression contributes to HCC growth and metastasis.Furthermore,several different types of antibodies targeting GPC3 have been developed.The aim of this review is to summarize the current literatures on the GPC3 expression in human HCC,molecular mechanisms of GPC3 regulation and antibodies targeting GPC3.
